Aurora Cannabis Inc stock page - price, fundamentals, dividends - iOCharts

Ticker
ACB

Price
1.89
Stock movement up
+0.14 (8.00%)
Company name
Aurora Cannabis Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers-Specialty & Generic
Market cap
562.74M
Ent value
613.01M
Price/Sales
2.49
Price/Book
0.52
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-72.12%
3 year return
-70.43%
5 year return
-39.22%
10 year return
-
Last updated: 2022-08-15

DIVIDENDS

ACB does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.49
Price to Book0.52
EV to Sales2.72

FINANCIALS

Per share

Loading...
Per share data
Current share count297.75M
EPS (TTM)-5.47
FCF per share (TTM)-0.44

Income statement

Loading...
Income statement data
Revenue (TTM)225.73M
Gross profit (TTM)36.77M
Operating income (TTM)-217.01M
Net income (TTM)-1.23B
EPS (TTM)-5.47
EPS (1y forward)-0.35

Margins

Loading...
Margins data
Gross margin (TTM)16.29%
Operating margin (TTM)-96.13%
Profit margin (TTM)-543.71%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash429.89M
Net receivables38.47M
Total current assets696.63M
Goodwill146.13M
Intangible assets346.58M
Property, plant and equipment0.00
Total assets1.57B
Accounts payable8.57M
Short/Current long term debt388.14M
Total current liabilities119.06M
Total liabilities480.16M
Shareholder's equity1.09B
Net tangible assets593.41M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-63.77M
Capital expenditures (TTM)34.41M
Free cash flow (TTM)-98.18M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-112.59%
Return on Assets-78.16%
Return on Invested Capital-88.56%
Cash Return on Invested Capital-7.08%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.75
Daily high1.94
Daily low1.73
Daily Volume23.5M
All-time high141.66
1y analyst estimate5.14
Beta3.04
EPS (TTM)-5.47
Dividend per share-
Ex-div date-
Next earnings date26 Sep 2022

Downside potential

Loading...
Downside potential data
ACBS&P500
Current price drop from All-time high-98.67%-10.22%
Highest price drop-99.13%-56.47%
Date of highest drop16 Jun 20229 Mar 2009
Avg drop from high-59.00%-11.38%
Avg time to new high47 days12 days
Max time to new high1149 days1805 days
COMPANY DETAILS
ACB (Aurora Cannabis Inc) company logo
Marketcap
562.74M
Marketcap category
Small-cap
Description
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Employees
1761
SEC filings
CEO
Michael Singer
Country
USA
City
Edmonton
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Canadian cannabis stocks soared Monday morning, with Tilray Brands (NASDAQ: TLRY), Canopy Growth (NASDAQ: CGC), and Aurora Cannabis (NASDAQ: ACB) spiking between 11% and 17% in earlier trading. As of...
August 15, 2022
Trulieve CEO Kim Rivers sits down with Yahoo Finance Live to discuss the cannabis company's latest earnings report and outlook ahead of cannabis regulation bills.
August 10, 2022
After tumbling on Friday following a lousy earnings report from Canopy Growth (NASDAQ: CGC), shares of fellow Canadian marijuana stocks Tilray (NASDAQ: TLRY) and Aurora Cannabis (NASDAQ: ACB) -- and C...
August 8, 2022
Green Thumb Industries Founder and CEO Ben Kovler breaks down the cannabis company's second-quarter earnings beat while diving into the outlook of marijuana legalization and marijuana conviction turno...
August 4, 2022
Tilray CEO Irwin Simon joins Yahoo Finance Live to discuss earnings, cannabis legalization, and the outlook for the market for marijuana.
August 4, 2022
Tilray, and Jefferies & Co., too. It's a slow news day in general for the marijuana industry, with little new having happened since Tilray reported its earnings last week -- or rather its losses. Ti...
August 2, 2022
Regrettably, Aurora Cannabis (NASDAQ: ACB) hasn't been a good growth stock for most of its investors. Debt is only one component of Aurora's issues, but it's hard to argue that less is better. While...
August 2, 2022
Marijuana stocks are down big this year. A couple of larger marijuana companies that might be worth considering are Aurora Cannabis (NASDAQ: ACB) and Sundial Growers (NASDAQ: SNDL). Rather than high...
July 29, 2022
In this article, we discuss 10 medical marijuana stocks to buy now. If you want to see more stocks in this list, check out 5 Medical Marijuana Stocks to Buy Now. Medical Marijuana, also called medical...
July 28, 2022
Cannabis company is seen losing 8 cents a share amid tough market conditions in Canada, but one analyst eyes more traction in recent weeks.
July 27, 2022
Next page